Literature DB >> 12902500

T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice.

James M Beck1, Michael B Blackmon, Christine M Rose, Stephanie L Kimzey, Angela M Preston, Jonathan M Green.   

Abstract

Loss of T cell number and function during HIV infection or secondary to pharmacologic immunosuppression renders individuals susceptible to opportunistic infections, including Pneumocystis carinii pneumonia. Because costimulatory receptors are critical for optimal T cell function, we hypothesized that these proteins would regulate susceptibility to opportunistic infections. We found that despite normal T cell numbers, mice deficient in the costimulatory molecules CD2 and CD28 spontaneously developed P. carinii pneumonia. In experiments using intratracheal injection of P. carinii organisms to induce infection, the loss of CD28 alone was sufficient to render mice susceptible to acute infection; however, the organism was eventually cleared. Examination of inflammatory responses to P. carinii revealed that mice deficient in both CD2 and CD28 accumulated CD8(+) T cells in their lungs in response to infection and demonstrated markedly reduced specific Ab titers. Analysis of cytokine profiles suggested that regulation of IL-10 and IL-15 may be important elements of the response to this pathogen. Thus, costimulatory molecule function is critical in determining the initial susceptibility to infection with P. carinii. Analysis of immunologic responses in these mice may provide important insights into the defects that render individuals susceptible to opportunistic infection, and provide opportunities for novel immunologically based therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902500     DOI: 10.4049/jimmunol.171.4.1969

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 2.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis.

Authors:  Maíra Felonato; Adriana Pina; Simone Bernardino; Flávio V Loures; Eliseu Frank de Araujo; Vera L G Calich
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

4.  Multifactorial relationships between intramammary invasion by Staphylococcus aureus and bovine leukocyte markers.

Authors:  Ariel L Rivas; Steven J Schwager; Rubén N González; Fred W Quimby; Kevin L Anderson
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

5.  Role for the CD28 molecule in the control of Coxiella burnetii infection.

Authors:  Amélie Honstettre; Soraya Meghari; Jacques A Nunès; Hubert Lepidi; Didier Raoult; Daniel Olive; Jean-Louis Mege
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

6.  CD2 deficiency partially prevents small bowel inflammation and improves parasite control in murine Toxoplasma gondii infection.

Authors:  Nina-N Pawlowski; Daniela Struck; Katja Grollich; Anja-A Kuhl; Martin Zeitz; Oliver Liesenfeld; Jorg-C Hoffmann
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

Review 7.  Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments.

Authors:  Aaron D Gingerich; Karen A Norris; Jarrod J Mousa
Journal:  Pathogens       Date:  2021-02-19

8.  Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.

Authors:  Elena N Atochina; James M Beck; Angela M Preston; Angela Haczku; Yaniv Tomer; Seth T Scanlon; Trevor Fusaro; John Casey; Samuel Hawgood; Andrew J Gow; Michael F Beers
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.